Notable Labs Protocol N-01: An Observational Study to Collect and Assess Tissue Samples from Subjects With Documented Hematologic Malignancy (ANSWer)

Study identification

• EU PAS number:
  EUPAS39233
• Study ID:
  39234
• Official title and acronym:
  Notable Labs Protocol N-01: An Observational Study to Collect and Assess Tissue Samples from Subjects With Documented Hematologic Malignancy (ANSWer)
• DARWIN EU® study:
  No
• Study countries:
  Greece

  Spain

  United States
• Study description:
  This is a prospective, multicenter observational study to collect clinically annotated biospecimens in order to assess the correlation between ex vivo data generated by the Notable assay platform and clinical outcome.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Notable Labs

Study timelines

Date when funding contract was signed

Planned: 01/01/2019

Actual: 01/01/2019

Study start date

Planned: 03/12/2019

Actual: 13/12/2019

Date of final study report

Planned: 20/12/2023

Sources of funding

Other

More details on funding

Notable Labs

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable